Cell Therapeutics

Seattle, WA: (Apr-17-07) The US government filed charges against Seattle biotechnology company, Cell Therapeutics, accusing it of promoting an anti-cancer drug, Trisenox, for uses that were not approved by the Food and Drug Administration. The suit stated that Cell Therapeutics subverted a regulatory system designed to assure that patients receive only those drugs that have been proven to be effective for their illness. Trisenox, which had received FDA approval for treating only one type of cancer, was allegedly being promoted for various uses as well. Physicians who used the drugs for off label purposes submitted false claims or reimbursement to the Medicare program, a move that the government said allowed Cell Therapeutics to enrich itself at the taxpayers expense. In order to resolve claims and investigations by the Justice Department, Cell Therapeutics has agreed to pay $10.5 million. [SEATTLE POST INTELLIGENCER: TRISENOX OFF-LABEL]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.
Published on Apr-20-07